Does ERENUMAB Cause Neovascularisation? 14 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Neovascularisation have been filed in association with ERENUMAB (AIMOVIG). This represents 1.2% of all adverse event reports for ERENUMAB.
14
Reports of Neovascularisation with ERENUMAB
1.2%
of all ERENUMAB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Neovascularisation From ERENUMAB?
Of the 14 reports.
Is Neovascularisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERENUMAB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does ERENUMAB Cause?
Off label use (293)
Migraine (285)
Drug ineffective (280)
Gastrooesophageal reflux disease (236)
Drug intolerance (227)
Vomiting (220)
Pain (217)
Abdominal pain upper (210)
Blepharospasm (209)
Hypoaesthesia (204)
What Other Drugs Cause Neovascularisation?
LAMOTRIGINE (62)
PREDNISONE (60)
PROPRANOLOL (60)
AMLODIPINE (59)
ATENOLOL (59)
DIHYDROERGOTAMINE (59)
GABAPENTIN (59)
METOCLOPRAMIDE (59)
NADOLOL (59)
NAPROXEN (59)
Which ERENUMAB Alternatives Have Lower Neovascularisation Risk?
ERENUMAB vs ERENUMAB-AOOE
ERENUMAB vs ERENUMAB\ERENUMAB-AOOE
ERENUMAB vs ERGOCALCIFEROL
ERENUMAB vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL
ERENUMAB vs ERIBULIN